Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review
Crossref DOI link: https://doi.org/10.1038/s41393-022-00853-3
Published Online: 2022-09-09
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Akkoc, Yesim http://orcid.org/0000-0003-0480-499X
Text and Data Mining valid from 2022-09-09
Version of Record valid from 2022-09-09
Article History
Received: 24 November 2021
Revised: 26 August 2022
Accepted: 29 August 2022
First Online: 9 September 2022
Competing interests
: The author declares no competing interests.